![A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder | SpringerLink A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40272-020-00409-z/MediaObjects/40272_2020_409_Fig1_HTML.png)
A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder | SpringerLink
![Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates | Journal of Neuroscience Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/39/8/1436/F4.large.jpg)
Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates | Journal of Neuroscience
![Figure 1 from A Comparison of Ritalin and Adderall: Efficacy and Time-course in Children With Attention-deficit/Hyperactivity Disorder | Semantic Scholar Figure 1 from A Comparison of Ritalin and Adderall: Efficacy and Time-course in Children With Attention-deficit/Hyperactivity Disorder | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a5908431630e8fc48d7b14bf869d213cd3cdfa5f/9-Figure1-1.png)
Figure 1 from A Comparison of Ritalin and Adderall: Efficacy and Time-course in Children With Attention-deficit/Hyperactivity Disorder | Semantic Scholar
A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate i
Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats | PLOS ONE
![These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA® (methylphenidate hydrochloride) extended-release capsules for oral use, These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA® (methylphenidate hydrochloride) extended-release capsules for oral use,](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=ritalin-la-03.jpg&id=664269)
These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA® (methylphenidate hydrochloride) extended-release capsules for oral use,
![Dose–response curves for methylphenidate (panels A–C) and amphetamine... | Download Scientific Diagram Dose–response curves for methylphenidate (panels A–C) and amphetamine... | Download Scientific Diagram](https://www.researchgate.net/publication/357835191/figure/fig1/AS:1155101217554437@1652408999968/Dose-response-curves-for-methylphenidate-panels-A-C-and-amphetamine-panels-D-F_Q320.jpg)
Dose–response curves for methylphenidate (panels A–C) and amphetamine... | Download Scientific Diagram
![Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression | Nature Communications Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncomms3720/MediaObjects/41467_2013_Article_BFncomms3720_Fig1_HTML.jpg)
Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression | Nature Communications
![Risk factors for low adherence to methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder | Scientific Reports Risk factors for low adherence to methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-81416-z/MediaObjects/41598_2021_81416_Fig1_HTML.png)
Risk factors for low adherence to methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder | Scientific Reports
![PDF) Pharmacokinetics of Methylphenidate After Oral Administration of Two Modified-Release Formulations in Healthy Adults PDF) Pharmacokinetics of Methylphenidate After Oral Administration of Two Modified-Release Formulations in Healthy Adults](https://www.researchgate.net/profile/John-Markowitz-2/publication/10846462/figure/fig2/AS:328409675780097@1455310376702/Representative-concentration-time-profiles-of-DL-threomethylphenidate-from-two-healthy_Q320.jpg)
PDF) Pharmacokinetics of Methylphenidate After Oral Administration of Two Modified-Release Formulations in Healthy Adults
![Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression | Nature Communications Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms3720/MediaObjects/41467_2013_Article_BFncomms3720_Fig5_HTML.jpg)
Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression | Nature Communications
![Comparative efficacy of Concerta®(18, 36 mg) and Ritalin LA®(20 mg)... | Download Scientific Diagram Comparative efficacy of Concerta®(18, 36 mg) and Ritalin LA®(20 mg)... | Download Scientific Diagram](https://www.researchgate.net/publication/257202727/figure/fig3/AS:202535299227650@1425299586196/Comparative-efficacy-of-ConcertaR18-36mg-and-Ritalin-LAR20mg-versus-placebo-in-a.png)
Comparative efficacy of Concerta®(18, 36 mg) and Ritalin LA®(20 mg)... | Download Scientific Diagram
![Pharmacokinetic profiles of sustained-release methylphenidate and newer... | Download Scientific Diagram Pharmacokinetic profiles of sustained-release methylphenidate and newer... | Download Scientific Diagram](https://www.researchgate.net/profile/John-Markowitz-2/publication/9030063/figure/fig4/AS:561759997763586@1510945428213/Pharmacokinetic-profiles-of-sustained-release-methylphenidate-and-newer-extended-release_Q640.jpg)
Pharmacokinetic profiles of sustained-release methylphenidate and newer... | Download Scientific Diagram
![Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations - Incledon - 2022 - Clinical Pharmacology in Drug Development - Wiley Online Library Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations - Incledon - 2022 - Clinical Pharmacology in Drug Development - Wiley Online Library](https://accp1.onlinelibrary.wiley.com/cms/asset/b44e9ab4-2e51-4015-ab4e-a23ac2a1b1b3/cpdd1089-fig-0002-m.jpg)
Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations - Incledon - 2022 - Clinical Pharmacology in Drug Development - Wiley Online Library
![A Simulation Study of the Comparative Performance of Partial Area under the Curve (pAUC) and Partial Area under the Effect Curve (pAUEC) Metrics in Crossover Versus Replicated Crossover Bioequivalence Studies for Concerta A Simulation Study of the Comparative Performance of Partial Area under the Curve (pAUC) and Partial Area under the Effect Curve (pAUEC) Metrics in Crossover Versus Replicated Crossover Bioequivalence Studies for Concerta](https://media.springernature.com/lw685/springer-static/image/art%3A10.1208%2Fs12248-022-00726-w/MediaObjects/12248_2022_726_Fig1_HTML.png)